Universal Cytomegalovirus Screening in the First Trimester of Pregnancy: The Multicentre Observational Cohort Study in the Area of Barcelona ( CITEMB Study)
BJOG: An International Journal of Obstetrics & Gynaecology · 2026
DOI: 10.1111/1471-0528.70137 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2026. Verfasst von María Ángeles Sánchez-Durán und 21 weiteren Autor:innen. Beteiligte Einrichtung: Maternal Fetal Medicine Unit, Department of Obstetrics, Vall D'hebron Barcelona Hospital Campus, Barcelona, Spain. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Pregnancy Complications, Infectious. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Departament de Salut, Generalitat de Catalunya.
Abstract (Originalsprache)
Objective
To determine the CMV seroprevalence among pregnant women and assess the rate of primary CMV infections during the first trimester.
Design
Prospective multicentre observational cohort study.
Setting
Four primary care centres (ASSIRs) and two tertiary hospitals in Barcelona and its metropolitan area. Pupulation or Sample Pregnant women attending first‐trimester antenatal visits between October 2022 and September 2024.
Methods
All participants underwent CMV IgG and IgM serological testing at the first antenatal visit. Women with positive IgM and low or intermediate IgG avidity were diagnosed with primary CMV infection and managed according to local protocols, including treatment with valaciclovir and fetal follow‐up. Main Outcome Measures CMV screening acceptance rate, seroprevalence, rate of primary infection, fetal infection, and neonatal outcomes up to one year of age.
Results
Of 3 677 pregnant women recruited, 3 357 were included in the final analysis. CMV screening acceptance was high. Seroprevalence was 77.7% (95% CI 76.2%–79.1%), and 743 women (22.1%, 95% CI 20.7%–23.6%) were seronegative. Five cases (0.15%, 95% CI 0.05%–0.37%) of primary CMV infection were identified and treated. No fetal infections were detected by amniocentesis. One newborn tested positive for CMV but remained asymptomatic at birth and at 6 months. Women who were seronegative were generally older, of European origin, and had higher education and employment rates.
Conclusions
Universal first‐trimester CMV screening is feasible and well accepted in a public healthcare setting. While the rate of primary infection was low, early identification of seronegative women offers opportunities for preventive counselling and targeted follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Maternal Fetal Medicine Unit, Department of Obstetrics, Vall D'hebron Barcelona Hospital Campus, Barcelona, Spain.
- Universitat Autònoma de Barcelona, Bellaterra, Spain.
- Department of Microbiology, Vall D'hebron Barcelona Hospital Campus, Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III. Madrid, Spain.
- Atencio a la Salut Sexual i Reproductiva (ASSIR) Esquerra, Institut Català de la Salut, Barcelona, Spain.
- Atencio a la Salut Sexual i Reproductiva (ASSIR) Muntanya, Institut Català de la Salut, Barcelona, Spain.
ORCID-Profile: María Ángeles Sánchez-Durán, Juliana Esperalba, Elena Scazzocchio, Irene Fernández-Torm, Eva Vázquez-Segura, Olga Gracia-Salazar, Marta Calveiro-Hermo, Jordina Munrós-Feliu, Astrid Francesch-Campi, Laia Alcoverro-Bedos, Aleida Ribas-Tristany, Cristina Del Viso-Lajara, Julia Mitjans-Carrasco, Mercedes Guerrero-Martínez, Gema Fernández-Rivas, Aneta Monika Zientalska, Liudmila Liutsko, Gemma Falguera-Puig, Cristina Martínez-Bueno, Nerea Maiz, Roser Gol
Förderung
- Departament de Salut, Generalitat de Catalunya
Zitieren
APA
Sánchez-Durán, M. Á., Esperalba, J., Scazzocchio, E., Fernández-Torm, I., Vázquez-Segura, E., Gracia-Salazar, O., Calveiro-Hermo, M., Munrós-Feliu, J., Francesch-Campi, A., Alcoverro-Bedos, L., Ribas-Tristany, A., Del Viso-Lajara, C., Mitjans-Carrasco, J., Guerrero-Martínez, M., Fernández-Rivas, G., Zientalska, A. M., Liutsko, L., Falguera-Puig, G., Martínez-Bueno, C., …, & CITEMB group (2026). Universal Cytomegalovirus Screening in the First Trimester of Pregnancy: The Multicentre Observational Cohort Study in the Area of Barcelona ( CITEMB Study). BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.70137
Vancouver
Sánchez-Durán MÁ, Esperalba J, Scazzocchio E, Fernández-Torm I, Vázquez-Segura E, Gracia-Salazar O, et al. Universal Cytomegalovirus Screening in the First Trimester of Pregnancy: The Multicentre Observational Cohort Study in the Area of Barcelona ( CITEMB Study). BJOG: An International Journal of Obstetrics & Gynaecology. 2026. doi:10.1111/1471-0528.70137
BibTeX
@article{SnchezDurn2026,
author = {Sánchez-Durán, María Ángeles and Esperalba, Juliana and Scazzocchio, Elena and Fernández-Torm, Irene and Vázquez-Segura, Eva and Gracia-Salazar, Olga and Calveiro-Hermo, Marta and Munrós-Feliu, Jordina and Francesch-Campi, Astrid and Alcoverro-Bedos, Laia and Ribas-Tristany, Aleida and Del Viso-Lajara, Cristina and Mitjans-Carrasco, Julia and Guerrero-Martínez, Mercedes and Fernández-Rivas, Gema and Zientalska, Aneta Monika and Liutsko, Liudmila and Falguera-Puig, Gemma and Martínez-Bueno, Cristina and Maiz, Nerea and Gol, Roser and CITEMB group, CITEMB group},
title = {Universal Cytomegalovirus Screening in the First Trimester of Pregnancy: The Multicentre Observational Cohort Study in the Area of Barcelona ( CITEMB Study)},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2026},
doi = {10.1111/1471-0528.70137}
}
EUVIMED